DOI: http://dx.doi.org/10.18203/2349-3291.ijcp20193727

Investigation of Von Willebrand disease in children with epistaxis and clinical practical approach

Hakan Sarbay

Abstract


Background: The absence of a standardized approach to the disease and bleeding history can lead to unnecessary patient consultations and sometimes late diagnosis. The aim of this study was to investigate von Willebrand disease (VWD) in patients presenting with epistaxis with clinical practical approach.

Methods: 63 Patients who were admitted to the pediatric hematology and oncology clinic between June 2017 and June 2018 with a complaint of epistaxis were evaluated. Patients diagnosed with VWD were classified as group 1, patients without VWD considered as group 2. The two groups were compared in terms of number of additional symptoms, and family history.

Results: There was no difference in terms of age and gender when compared with 42 patients not considered as VWD (group 2), number of additional symptoms, and family history were significantly higher in the group considered as VWD.

Conclusions: Excess number of additional bleeding symptoms, and bleeding history in family are of importance for the suspicion of diagnosis of VWD for physicians with limited experience in terms of bleeding disorders in primary and secondary health care institutions.


Keywords


Bleeding, Bleeding disorders, Bleeding symptoms, Epistaxis, Mucocutaneous menorrhagia, Von willebrand disease

Full Text:

PDF

References


Sadler JE, Mannucci PM, Berntorp E, Bochkov N, Boulyjenkov V, Ginsburg D, et al. Impact, diagnosis and treatment of von Willebrand disease, Thromb Haemost. 2000 Aug:84(2);160-74.

Sadler JE, Budde U, Eikenboom JC, Favaloro EJ, Hill FG, Holmberg L, et al. Update on the pathophysiology and classification of von Willebrand disease: a report of the Subcommittee on von Willebrand Factor, J ThrombHaemost. 2006 Oct Epub 2006 Aug 2;4(10):2103-14.

Katsanis E, Luke KH, Hsu E, Li M, Lillicrap D. Prevalence and significance of mild bleeding disorders in children with recurrent epistaxis, J Pediatr. 1988 Jul 1;113(1):73-6.

Bowman M, Riddel J, Rand ML, Tosetto A, Silva M, James PD. Evaluation of the diagnostic utility for von Willebrand disease of a pediatric bleeding questionnaire. J thrombo haemosta. 2009 Aug;7(8):1418-21.

Bowman ML, James PD. Bleeding scores for the diagnosis of von Willebrand disease. Semin Thromb Hemost. 2017 Jul;43(05)530-9.

Sanders YV, Fijnvandraat K, Boender J, Mauser-Bunschoten EP, van der Bom JG, de Meris J, WiN study group, Bleeding spectrum in children with moderate or severe von Willebrand disease: Relevance of pediatric-specific bleeding, Am J Hematol. 2015 Dec;90(12):1142-8.

Mauer AC, Khazanov NA, Levenkova N, Tian S, Barbour EM, Khalida C, et al. Impact of sex, age, race, ethnicity and aspirin use on bleeding symptoms in healthy adults. J Thromb Haemost. 2011 Jan;9(1):100-8.

Rodeghiero F, Castaman G, Dini E. Epidemiological investigation of the prevalence of von Willebrand’s disease. Blood. 1987 Feb 1;69(2):454-9.

Werner EJ, Broxson EH, Tucker EL, Giroux DS, Shults J, Abshire TC. Prevalence of von Willebrand disease in children: a multiethnic study. J Pediatr. 1993 Dec 1;123(6):893-8.

Rodeghiero F, Tosetto A, Abshire T, Arnold DM, Coller B, James P, et al. ISTH/SSC bleeding assessment tool: a standardized questionnaire and a proposal for a new bleeding score for inherited bleeding disorders. J Thromb Haemost. 2010 Sep;8(9):2063-5.

Mittal N, Pedersen R, James P, Shott S, Valentino LA. Utility of a pediatric Bleeding Questionnaire as a screening tool for von Willebrand Disease in apparently healthy children. Haemophilia. 2015 Nov;21(6):806-11.

Boscardini L, Zanetta S, Ballardini G, Angellotti P, Gramatica P, Scotti A, et al. Epistaxis in children under the age of two: Possible marker of abuse/neglect? A retrospective study in North-Eastern Piedmont hospitals. Minerva Pediatrica. 2013 Feb;65(1):71-5.

Record S. Practice Guideline: Epistaxis in Children. J Pediatr Health Care. 2015 Sep-Oct;29(5):484-8.

Tosetto A, Rodeghiero F, Castaman G, Goodeve A, Federici AB, Batlle J, et al. A quantitative analysis of bleeding symptoms in type 1 von Willebrand disease: results from a multicenter European study. J Thromb Haemost. 2006 Apr;4(4):766-73.

Goodeve AC. The genetic basis of von Willebrand disease. Blood Rev. 2010 May 1;24(3):123-34.

Berber E. The Molecular Genetics of von Willebrand Disease. Turk J Haematol. 2012 Dec;29(4):313-24.